Biological characterization of ovarian cancer: prognostic and therapeutic implications
Open Access
- 1 May 2005
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 16 (suppl_4) , iv95-iv101
- https://doi.org/10.1093/annonc/mdi916
Abstract
1Gynecologic Oncology Unit, Catholic University, Rome; 2Oncology Department, Catholic University, CampobassoKeywords
This publication has 44 references indexed in Scilit:
- Gene Expression Signature With Independent Prognostic Significance in Epithelial Ovarian CancerJournal of Clinical Oncology, 2004
- RETRACTED: The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter studyGynecologic Oncology, 2004
- Cyclin D1, p53, and p21Waf1/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian CancerClinical Cancer Research, 2004
- Overexpression of Cyclin D1 Is Associated with Poor Survival in Epithelial Ovarian CancerOncology, 2004
- Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancerGynecologic Oncology, 2004
- Cancer mortality in Europe, 1995–1999, and an overview of trends since 1960International Journal of Cancer, 2004
- Drug resistance reversal—are we getting closer?European Journal Of Cancer, 2003
- Cyclooxygenase-2 (COX-2), Epidermal Growth Factor Receptor (EGFR), and Her-2/neu Expression in Ovarian CancerGynecologic Oncology, 2002
- EGFR and cancer prognosisPublished by Elsevier ,2001
- The Cell CycleThe International Journal of Cell Cloning, 2001